Cargando…
Persisting Type 2 Endoleaks Following EVAR for AAA Are Associated With AAA Expansion
PURPOSE: To determine the evolution of abdominal aortic aneurysm (AAA) diameter in the presence of persisting type 2 endoleaks (pEL2) following endovascular abdominal aortic aneurysm repair (EVAR). MATERIALS AND METHODS: This is a retrospective, single-center, case-control study. All patients with p...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209501/ https://www.ncbi.nlm.nih.gov/pubmed/35236157 http://dx.doi.org/10.1177/15266028221081079 |
_version_ | 1785046888758640640 |
---|---|
author | Hatzl, Johannes Wang, Vivian Hakimi, Maani Uhl, Christian Rengier, Fabian Bruckner, Thomas Böckler, Dittmar |
author_facet | Hatzl, Johannes Wang, Vivian Hakimi, Maani Uhl, Christian Rengier, Fabian Bruckner, Thomas Böckler, Dittmar |
author_sort | Hatzl, Johannes |
collection | PubMed |
description | PURPOSE: To determine the evolution of abdominal aortic aneurysm (AAA) diameter in the presence of persisting type 2 endoleaks (pEL2) following endovascular abdominal aortic aneurysm repair (EVAR). MATERIALS AND METHODS: This is a retrospective, single-center, case-control study. All patients with pEL2 (pEL2 group, persisting for > 12 months) between 2004 and 2018 were identified and compared with a 1:1 age- and gender-matched control with no endoleak (control group). Primary outcome measures were freedom from AAA expansion and freedom from AAA shrinkage over time. AAA diameter measurements were performed on computed tomography angiography (CTA). Secondary outcome measures were survival, AAA-related mortality, reinterventions for pEL2, incidence of secondary type 1 endoleaks (EL1), and infrarenal aortic branch vessel anatomy. RESULTS: A total of 773 patients were treated with EVAR for AAA between 2004 and 2018. Of them, 286 patients demonstrated type 2 endoleaks (EL2) in postoperative CTA or intraoperative angiography (37%). Forty-five of 286 EL2 (15.7%) were pEL2 (pEL2 group). Freedom from AAA expansion in the pEL2 group was 100%, 96.7%, 85.2%, and 54.3% after 1, 2, 3, and 4 years, respectively, compared with 100% after 1, 2, 3, and 4 years in the control group (p<0.01). Freedom from AAA shrinkage in the pEL2 group after 1, 2, 3, and 4 years was 95.5%, 90.4%, 90.4%, and 79.1%, respectively, compared with 86.7%, 34.8%, 19.3%, and 19.3% in the control group (p<0.01). Overall survival at 1, 2, 3, and 4 years was 100%, 97.6%, 95.0% and 95.0% in the pEL2 group and 100% at 1, 2, 3, and 4 years in the control group (p=0.17). There were no AAA-related deaths in either group. Patients with pEL2 had a significantly increased number of infrarenal aortic branches (p<0.05, respectively). Eighteen patients (40.0%) in the pEL2 group underwent 34 reinterventions for pEL2, with a median follow-up (FU) of 925 days (0–4173). Clinical success was achieved in 9 patients (50.0%). Four patients (8.9%) with pEL2 developed secondary EL1 after a median FU of 1278 days (662–2121). CONCLUSION: pEL2 are associated with AAA expansion during midterm FU. Further studies are warranted to evaluate the association of AAA expansion due to pEL2 with clinical outcomes to allow recommendations with regard to treatment indications. |
format | Online Article Text |
id | pubmed-10209501 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-102095012023-05-26 Persisting Type 2 Endoleaks Following EVAR for AAA Are Associated With AAA Expansion Hatzl, Johannes Wang, Vivian Hakimi, Maani Uhl, Christian Rengier, Fabian Bruckner, Thomas Böckler, Dittmar J Endovasc Ther Clinical Investigations PURPOSE: To determine the evolution of abdominal aortic aneurysm (AAA) diameter in the presence of persisting type 2 endoleaks (pEL2) following endovascular abdominal aortic aneurysm repair (EVAR). MATERIALS AND METHODS: This is a retrospective, single-center, case-control study. All patients with pEL2 (pEL2 group, persisting for > 12 months) between 2004 and 2018 were identified and compared with a 1:1 age- and gender-matched control with no endoleak (control group). Primary outcome measures were freedom from AAA expansion and freedom from AAA shrinkage over time. AAA diameter measurements were performed on computed tomography angiography (CTA). Secondary outcome measures were survival, AAA-related mortality, reinterventions for pEL2, incidence of secondary type 1 endoleaks (EL1), and infrarenal aortic branch vessel anatomy. RESULTS: A total of 773 patients were treated with EVAR for AAA between 2004 and 2018. Of them, 286 patients demonstrated type 2 endoleaks (EL2) in postoperative CTA or intraoperative angiography (37%). Forty-five of 286 EL2 (15.7%) were pEL2 (pEL2 group). Freedom from AAA expansion in the pEL2 group was 100%, 96.7%, 85.2%, and 54.3% after 1, 2, 3, and 4 years, respectively, compared with 100% after 1, 2, 3, and 4 years in the control group (p<0.01). Freedom from AAA shrinkage in the pEL2 group after 1, 2, 3, and 4 years was 95.5%, 90.4%, 90.4%, and 79.1%, respectively, compared with 86.7%, 34.8%, 19.3%, and 19.3% in the control group (p<0.01). Overall survival at 1, 2, 3, and 4 years was 100%, 97.6%, 95.0% and 95.0% in the pEL2 group and 100% at 1, 2, 3, and 4 years in the control group (p=0.17). There were no AAA-related deaths in either group. Patients with pEL2 had a significantly increased number of infrarenal aortic branches (p<0.05, respectively). Eighteen patients (40.0%) in the pEL2 group underwent 34 reinterventions for pEL2, with a median follow-up (FU) of 925 days (0–4173). Clinical success was achieved in 9 patients (50.0%). Four patients (8.9%) with pEL2 developed secondary EL1 after a median FU of 1278 days (662–2121). CONCLUSION: pEL2 are associated with AAA expansion during midterm FU. Further studies are warranted to evaluate the association of AAA expansion due to pEL2 with clinical outcomes to allow recommendations with regard to treatment indications. SAGE Publications 2022-03-03 2023-06 /pmc/articles/PMC10209501/ /pubmed/35236157 http://dx.doi.org/10.1177/15266028221081079 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 Lficense (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Clinical Investigations Hatzl, Johannes Wang, Vivian Hakimi, Maani Uhl, Christian Rengier, Fabian Bruckner, Thomas Böckler, Dittmar Persisting Type 2 Endoleaks Following EVAR for AAA Are Associated With AAA Expansion |
title | Persisting Type 2 Endoleaks Following EVAR for AAA Are Associated With AAA Expansion |
title_full | Persisting Type 2 Endoleaks Following EVAR for AAA Are Associated With AAA Expansion |
title_fullStr | Persisting Type 2 Endoleaks Following EVAR for AAA Are Associated With AAA Expansion |
title_full_unstemmed | Persisting Type 2 Endoleaks Following EVAR for AAA Are Associated With AAA Expansion |
title_short | Persisting Type 2 Endoleaks Following EVAR for AAA Are Associated With AAA Expansion |
title_sort | persisting type 2 endoleaks following evar for aaa are associated with aaa expansion |
topic | Clinical Investigations |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209501/ https://www.ncbi.nlm.nih.gov/pubmed/35236157 http://dx.doi.org/10.1177/15266028221081079 |
work_keys_str_mv | AT hatzljohannes persistingtype2endoleaksfollowingevarforaaaareassociatedwithaaaexpansion AT wangvivian persistingtype2endoleaksfollowingevarforaaaareassociatedwithaaaexpansion AT hakimimaani persistingtype2endoleaksfollowingevarforaaaareassociatedwithaaaexpansion AT uhlchristian persistingtype2endoleaksfollowingevarforaaaareassociatedwithaaaexpansion AT rengierfabian persistingtype2endoleaksfollowingevarforaaaareassociatedwithaaaexpansion AT brucknerthomas persistingtype2endoleaksfollowingevarforaaaareassociatedwithaaaexpansion AT bocklerdittmar persistingtype2endoleaksfollowingevarforaaaareassociatedwithaaaexpansion |